Clinical Trial Update: A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis [Phase 2]

View source ↗

Summary

Phase 2 randomized trial comparing edoxaban monotherapy to low molecular weight heparin/warfarin in symptomatic deep vein thrombosis; study completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Venous Thrombosis

Drugs mentioned

• Edoxaban (edoxaban)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Deep Vein Thrombosis, Venous Thrombosis | Phase 2 | Status: COMPLETED | Results posted: 2017-05-12